KEY TAKEAWAYS
·PDMS holds roughly 35% of the microfluidics market by material (2025) and is the final material in shipping organ-on-a-chip, liquid-biopsy, droplet and single-cell products.
·Five properties — gas permeability, optical clarity, elasticity, replication fidelity and bonding versatility — have no equivalent in an injection-moldable thermoplastic. A device that depends on any of them changes product when it changes material.
·Three drawbacks are real: small-molecule absorption, hydrophobic recovery and unit cost at very high volume. All three are answered in design — none is fixed by casting PDMS by hand.
Polydimethylsiloxane has spent twenty years being described as a prototyping material — something you use to prove a concept before you move to "real" manufacturing in thermoplastic. That description is now wrong often enough to be expensive. PDMS is the largest single material segment of the microfluidics market by material share [8], and a significant number of commercial instruments ship today with a PDMS consumable at the center of the workflow, not as a stopgap but as the product.
The reason PDMS acquired its reputation is not the polymer. It is the process that most groups use to form it — and that is the subject of Part 2. This part makes the case for the material itself.
\ PROPERTIES
Properties that thermoplastics do not replicate
The case for PDMS is not sentimental. It is a short list of physical properties that, taken together, no injection-moldable thermoplastic offers.
GAS PERMEABILITY
~800 Barrer O₂ ·
~3,800 Barrer CO₂
Oxygen and carbon dioxide permeabilities of roughly 800 and 3,800 Barrer allow cells to be cultured in a sealed device without an external gas exchanger. For organ-on-a-chip, organoid and long-duration culture work this is not a convenience — it is the enabling property [4].
REPLICATION FIDELITY
Features down to 2 µm
Near-vertical sidewalls, reproduced faithfully from a lithographic master — and reproduced at a tolerance that micro injection molding reaches only with difficulty.
OPTICAL CLARITY
Transparent from
~240 to 1,100 nm
Low autofluorescence across that window supports fluorescence imaging and label-free optical readout through the device wall.
BONDING VERSATILITY
Plasma bonds to glass and to itself
Strong plasma-activated bonds to glass and to PDMS, and a reversible bonding option that no thermoplastic assembly offers.
ELASTICITY
Young's modulus
~1.6–2.1 MPa
At the standard 10:1 base-to-curing-agent ratio. This is what makes pneumatic valves, deformable membranes, conformal seals and reversible bonding possible at all.
THE CONSEQUENCE
A change of material is a change of product
For a device whose function depends on any of these, a transfer to plastic is not a cost optimization — it is a change of product.
\ APPLICATIONS
Where PDMS ships as the final material
The pattern across the market is consistent: PDMS wins where biology, high-resolution features or elasticity dominate, and where annual volumes are in the thousands to low hundreds of thousands rather than the millions.
APPLICATION
WHY PDMS IS THE FINAL MATERIAL
TYPICAL ANNUAL VOLUME
Organ-on-a-chip / MPS
WHY PDMS IS THE FINAL MATERIAL
Gas exchange for sealed culture; deformable membranes for mechanical stimulus; optical access
TYPICAL ANNUAL VOLUME
1k – 50k
Liquid biopsy / rare-cell capture
WHY PDMS IS THE FINAL MATERIAL
High-aspect micro-pillar arrays; gentle, low-shear surfaces; conformal sealing to glass
TYPICAL ANNUAL VOLUME
10k – 200k
Droplet microfluidics
WHY PDMS IS THE FINAL MATERIAL
Fine junction geometry at tight tolerance; surface chemistry compatible with common oils
TYPICAL ANNUAL VOLUME
5k – 100k
Single-cell analysis / NGS prep
WHY PDMS IS THE FINAL MATERIAL
50 µm-class channels at ±1.5 µm; multi-layer valve structures
TYPICAL ANNUAL VOLUME
5k – 100k
Cell culture & drug screening
WHY PDMS IS THE FINAL MATERIAL
Biocompatibility, permeability, transparency; rapid design iteration
TYPICAL ANNUAL VOLUME
1k – 50k
\ LIMITATIONS
The drawbacks, stated plainly
The case for PDMS is not sentimental. It is a short list of physical properties that, taken together, no injection-moldable thermoplastic offers.
Small-molecule absorption
PDMS absorbs hydrophobic small molecules into its bulk. Published work finds essentially no binding for compounds below a LogP threshold of roughly 1.3–1.85, and strong binding above about 1.85, with in-device exposure shifted by up to an order of magnitude relative to nominal dose [2]. If your assay depends on precise dosing of a lipophilic compound, either calibrate for it, passivate the surface, or move that specific step to a non-absorbing material.
Hydrophobic recovery
Plasma-activated PDMS surfaces begin returning to their native hydrophobic state within about fifteen minutes, though thermal aging to remove low-molecular-weight species extends this substantially [3]. Surface chemistry must be specified as a process with a shelf life, not as a permanent property.
Unit cost at very high volume
PDMS is a cast-and-cure process with a cycle time measured in tens of minutes, not seconds. At sustained high volume, injection molding wins on unit cost — provided your chemistry tolerates the change. Where that crossover falls is product-specific; Part 4 gives the trigger conditions we use.
THE POINT
None of these three limitations is fixed by casting PDMS by hand in a laboratory. They are material and chemistry questions, and they are answered in design. What laboratory casting does add is a fourth set of problems — dimensional, contamination and throughput problems — and those are fixed by manufacturing.
Sources on this page: [2] Auner et al., Lab on a Chip 19, 864–874 (2019) · [3] Gokaltun et al., Technology 5, 1–12 (2017) · [4] Gokaltun et al., J. Mater. Chem. B (2023) · [8] Grand View Research, Microfluidics Market Size, Share & Trends Analysis Report (2025). Full list on the guide overview.
\ CONTINUE
Continue reading
The complete paper is available as a PDF (16 pages, 1 MB): Industrializing PDMS — a manufacturing and decision guide.
How an engagement runs
01. Proposal &
Contract
Timeline: 6 - 7 Weeks
From first conversation to purchase order — initial meeting and indicative quote, NDA, a written design evaluation, technical meeting, firm quote, contract.
02. Tooling & First Article
Timeline: 2 - 3 Weeks
Mold design, replication from the master pattern, and first-article inspection against your drawings.
03. Ramp & Mass Production
Timeline: Month 1 – Month 4+
Roughly 1,000 pieces in month one, 5,000 by month two, 20,000 by month four — up to 80,000 a month at full capacity.
\ START HERE
Request a quote
Send a CAD file, a schematic or a paper. We reply with a DFM review and a quote.